Early redemption of convertible bonds (incl. overseas CBs)

What happened

S Biomedics / Early Redemption of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity / (2026.08.13) Early Redemption of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity (5th Issue)

Early Redemption of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity Convertible bonds (including overseas convertible bonds), 5th issue

1. Matters concerning the bond acquired before maturity Type of bond: Unregistered, coupon, unsecured, privately placed convertible bonds Issue date: 2024-11-13 Method of issuance: Domestic issuance (private placement) Conversion price per share (KRW): 32,950 Maturity date: 2029-11-13

2. Bond acquisition amount (currency unit): 384,955,125 KRW: South Korean Won - Face value (electronically registered amount) of the acquired bond (currency unit): 375,000,000 KRW: South Korean Won - Applicable exchange rate: - - Acquisition date: 2026-08-13

3. Face value (electronically registered) total of the bond after acquisition (currency unit): 1,245,000,000 KRW: South Korean Won

4. Reason for acquisition before maturity and future handling method - Reason for acquisition: Exercise of the bondholder's early redemption request right (put option) - Future handling method: Future resale or retirement to be decided

5. Source of acquisition funds: Own funds

6. Method of bond acquisition: Over-the-counter purchase

7. Other matters for reference in investment decisions - The above "conversion price per share" is the conversion price as adjusted on 2026.01.13. - The above "acquisition date" is the date the bond acquisition amount was paid.

* Related disclosures 2024-11-13 Convertible Bond Issuance Decision (5th Issue) 2024-11-13 Securities Issuance Results (Voluntary Disclosure) (5th-issue CB) 2025-06-13 Adjustment of the Conversion Price (5th Issue) 2026-01-14 Adjustment of the Conversion Price (5th Issue)